Elsayed Balbaa: Baseline Anemia Predicts Adverse 12-Month Outcomes After Elective PCI for Stable CAD
Elsayed Balbaa, Student of Alexandria University, shared a post on LinkedIn:
“A new Publication!
We found that in men undergoing first-time elective PCI for stable CAD, baseline anemia was associated with higher 12-month risks of AKI, major bleeding, need for transfusion, hospitalization, and death, especially with recent (≤ 1 year) bleeding or transfusion history.”
Mohamed R. Murad, Bachelor of Medicine, Bachelor of Surgery – MBBS at Al-Azhar University, shared a post on LinkedIn:
“Pleased to share our recent publication:
‘Prognostic Impact of Baseline Anemia on Outcomes After Elective PCI in Men: A US Retrospective Cohort Study.’
In this study, we examined the prognostic impact of baseline anemia on outcomes after elective PCI in men with stable coronary artery disease.
Our analysis incorporated survival analysis, Kaplan-Meier curves, log-rank testing, univariable and multivariable Cox proportional hazards regression, propensity score matching, falsification (negative-control) endpoint analysis, E-value sensitivity analysis, and multiple-testing adjustment using Benjamini-Hochberg and Bonferroni methods.
I’m truly happy to be part of this great work with such outstanding leaders, collaborators, and team members.
I’m deeply grateful for the guidance, dedication, and shared effort of all co-authors who contributed to this study.
Proud to contribute to research that advances clinical understanding and supports better patient care.”
Title: Catheterization and Cardiovascular Interventions
Authors: Abdalhakim Shubietah, Mohamed S. Elgendy, Mohamed Saad Rakab, Ahmed Ahmed, Batoul Abusalah, Mohamed R. Murad, Belal Mohamed Hamed, Hamza A. Abdul-Hafez, Ahmed Emara, Qutaiba Qafisheh, Elsayed Balbaa, Ameer Awashra, Ahmed Mansour, Ahmed Elbataa, Abdalrahman Assaassa, Mohammed Mhanna
Read the Article on Catheterization and Cardiovascular Interventions
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care